City Drug House Exporters | Hepatitis Medicines Supplier to Washington, USA
City Drug House Exporters supplies and exports high-quality hepatitis medicines from India to Washington, USA with trusted pharma solutions and timely global delivery.
HEPCINAT 400 mg contains sofosbuvir, a direct-acting antiviral (DAA) medication. It is used in combination with other agents to treat chronic Hepatitis C virus (HCV) infections by inhibiting the NS5B RNA polymerase enzyme, effectively stopping the virus from replicating.
Mechanism of Action :
Active Metabolite: Upon ingestion, sofosbuvir acts as a prodrug. It is converted intracellularly into its active triphosphate form, 2'-deoxy-2'-alpha-fluoro-beta-C-methyluridine-5' monophosphate.
Viral Inhibition: This active triphosphate acts as a defective substrate for the HCV NS5B RNA-dependent RNA polymerase, which is essential for viral replication.
Chain Termination: When incorporated into the viral RNA, it causes chain termination, abruptly halting the creation of new Hepatitis C virus copies.
Pharmacokinetics
Absorption: It is rapidly absorbed, reaching peak plasma concentrations within 0.5 to 2 hours post-administration.
Food Effect: Taking the medication with a high-fat meal significantly delays absorption but has no clinically significant impact on the overall drug exposure.
Metabolism: Primarily metabolized in the liver to form the active triphosphate nucleotide.
Elimination: It is predominantly excreted via the kidneys approx 80% in the form of its primary inactive metabolite.
Clinical Usage & Regimen
Dosage: The standard adult dose is one 400 mg tablet taken orally, once daily. It is typically taken with food.
Combination Therapy: Sofosbuvir is rarely used as a monotherapy. It is generally administered alongside other antivirals (e.g., ledipasvir, daclatasvir, or ribavirin) to achieve a complete virologic cure.
Patient Groups: It is utilized for adults and pediatric patients aged 3 years and older with chronic Hepatitis C.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug House Exporters supplies and exports high-quality hepatitis medicines from India to Washington, USA with trusted pharma solutions and timely global delivery.
HEPCINAT 400 mg contains sofosbuvir, a direct-acting antiviral (DAA) medication. It is used in combination with other agents to treat chronic Hepatitis C virus (HCV) infections by inhibiting the NS5B RNA polymerase enzyme, effectively stopping the virus from replicating.
Mechanism of Action :
Active Metabolite: Upon ingestion, sofosbuvir acts as a prodrug. It is converted intracellularly into its active triphosphate form, 2'-deoxy-2'-alpha-fluoro-beta-C-methyluridine-5' monophosphate.
Viral Inhibition: This active triphosphate acts as a defective substrate for the HCV NS5B RNA-dependent RNA polymerase, which is essential for viral replication.
Chain Termination: When incorporated into the viral RNA, it causes chain termination, abruptly halting the creation of new Hepatitis C virus copies.
Pharmacokinetics
Absorption: It is rapidly absorbed, reaching peak plasma concentrations within 0.5 to 2 hours post-administration.
Food Effect: Taking the medication with a high-fat meal significantly delays absorption but has no clinically significant impact on the overall drug exposure.
Metabolism: Primarily metabolized in the liver to form the active triphosphate nucleotide.
Elimination: It is predominantly excreted via the kidneys approx 80% in the form of its primary inactive metabolite.
Clinical Usage & Regimen
Dosage: The standard adult dose is one 400 mg tablet taken orally, once daily. It is typically taken with food.
Combination Therapy: Sofosbuvir is rarely used as a monotherapy. It is generally administered alongside other antivirals (e.g., ledipasvir, daclatasvir, or ribavirin) to achieve a complete virologic cure.
Patient Groups: It is utilized for adults and pediatric patients aged 3 years and older with chronic Hepatitis C.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
